Navigation Links
Symmetry Medical Reports Third Quarter 2008 Financial Results
Date:11/12/2008

6,038 2,394

Derivative valuation liability - 74

Deferred income taxes 352 407

Revolving line of credit 7,477 6,511

Current portion of capital lease

obligations 1,393 2,487

Current portion of long-term debt 15,713 10,900

------ ------

Total current liabilities 80,159 76,309

Deferred income taxes 12,063 12,136

Derivative valuation liability 2,286 1,917

Capital lease obligations, less

current portion 3,603 4,032

Long-term debt, less current portion 126,825 68,500

------- ------

Total Liabilities 224,936 162,894

------- -------

Commitments and contingencies (Note 9)

Shareholders' Equity:

Common Stock, $.0001 par value; 72,410

shares authorized; shares issued

October 4, 2008--35,831; December 29,

2007--35,444) 4 4

Additional paid-in capital 274,994 272,623

Accumulated deficit (32,824) (45,526)

Accumulated other comprehensive income 7,268 10,435

----- ------

Total Shareholders' Equity 249,442 237,536

------- -------

Total Liabilities and Shareholders'

Equity $474,378 $400,430

======== ==
'/>"/>

SOURCE Symmetry Medical Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
2. Symmetry Medical Launches New Global Web site
3. Symmetry Medical Appoints John Hynes Chief Operating Officer, Europe
4. Symmetry Medical Provides Update of Previously Disclosed Accounting Review at Sheffield, UK Operating Unit
5. Symmetry Medical Completes Acquisition of DePuy Orthopaedic Instrument Facility
6. Symmetry Medical to Provide Fourth Quarter 2007 General Business Update on February 14, 2008
7. Facial asymmetry persists despite surgery to correct congenital deformity
8. Symmetry Medical to Expand Malaysian Operations
9. Symmetry Medical Delays 10-K Filing to Complete Review
10. Symmetry Medical Reports Full Year 2007 Financial Results
11. Symmetry Medical to Report First Quarter 2008 Financial Results on June 24, 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2009)... has become a mainstay of multiple myeloma treatment ... system of patients who have received stem cell ... early clinical trial results to be presented by ... American Society of Hematology,s (ASH) annual meeting on ... Convention Center, Room 243-245, 5:45 pm CT). , ...
(Date:12/6/2009)... by researchers from the Medical College of Wisconsin, in ... pain and other sickle cell disease complications in children. ... providers and patients were also identified. The study ... of pediatrics at the Medical College and Children,s Research ... presented at the American Society of Hematology meeting Dec. ...
(Date:12/6/2009)... 2009 A new study provides welcome news for ... thromboembolism (VTE). , The condition is estimated to ... occurs when an abnormal clot forms in a vein ... swelling. In some cases, the clot may detach from ... to the lungs, causing a potentially fatal condition known ...
(Date:12/5/2009)... combination has shown in a phase 1/2 clinical ... the treatment of patients newly diagnosed with multiple myeloma, ... say researchers from Dana-Farber Cancer Institute. , Partial responses ... patients treated with the drug combination in the multi-center ... response rate" in the phase 2 population, reports Paul ...
(Date:12/5/2009)... Blood Cancer Is Most Challenging-- ,, PHILADELPHIA ... identified specific genes, dubbed partner genes, that fuse with ... in infants. By more accurately defining specific partner genes, ... from particular treatments. ,, Oncologists also aim to ...
Breaking Medicine News(10 mins):Health News:Bortezomib shows promise in reducing GVHD and reconstituting immune system in some patients 2Health News:New study finds barriers to pain treatment in children with sickle cell disease 2Health News:New drug shows promise for those with clotting disorders: McMaster researcher 2Health News:Multiple myeloma patients experience high response rate with new 3-drug combination 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 2Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 3Health News:New Gene Findings Will Help Guide Treatment in Infant Leukemia 4
... of the threats to themselves and relatives, study says , , ... of families in which some members have BRCA1 or 2 ... ovarian cancer -- typically avoid genetic counseling or testing, a ... testing, they,re less likely than women to pass on the ...
... provide 50 free colonoscopies to patients impacted by the recent economic ... ... -- On Saturday, March 14, the physicians at Digestive Health Specialists ... screening colonoscopies to help those in our communities who have recently ...
... Included in Study Not Atkins DietDENVER, Feb. 27 ... (NEJM) study titled "Comparison of Weight-Loss Diets with ... 26, 2009), concluded that reduced-calorie diets result in ... (fat, protein and carbohydrates) they emphasize. Atkins ...
... surgeons at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis are reporting that artificial discs ... , Click here for more information. , ... , , , ... , , , ...
... FindingsNEWPORT NEWS, Va., Feb. 27 Women facing a ... the same or opposite breast with further testing using ... in the February 2009 "American Journal of Surgery." BSGI ... same or opposite breast in 10.9 percent of newly ...
... New Innovations and Technologies Aimed at Dentists and ConsumersCHICAGO, ... professionals will get a first look at the latest ... Midwinter Meeting. Held February 26 through March 1 at ... more than 570 exhibiting companies from around the world. ...
Other Medicine News:Health News:Men With BRCA Gene Mutations Unaware of Cancer Risks 2Health News:Men With BRCA Gene Mutations Unaware of Cancer Risks 3Health News:Local Gastroenterology Practice Gives Back to the Community During Colon Cancer Awareness Month 2Health News:Atkins Responds to Recent New England Journal of Medicine Weight-Loss Diets Study Results 2Health News:Atkins Responds to Recent New England Journal of Medicine Weight-Loss Diets Study Results 3Health News:Artificial disc replacement as good or better than spinal fusion surgery 2Health News:Artificial disc replacement as good or better than spinal fusion surgery 3Health News:Artificial disc replacement as good or better than spinal fusion surgery 4Health News:Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients 2Health News:Breast-Specific Gamma Imaging (BSGI) Uncovers Additional Breast Cancer in Newly Diagnosed Breast Cancer Patients 3Health News:One of North America's Largest Exhibitions of Dental Products Brings More than 30,000 Dental Professionals to Chicago 2Health News:One of North America's Largest Exhibitions of Dental Products Brings More than 30,000 Dental Professionals to Chicago 3
(Date:12/7/2009)... On December 8, Van Andel Institute (VAI) cuts ... square foot Phase II expansion. The expanded facility ... and West Michigan,s burgeoning life sciences sector and ... in infrastructure already in place along Grand Rapids, ... will support a $125 million annual research operation ...
(Date:12/7/2009)... Dec. 7 ,, 60 ... the trial The antibodies generated by the ... the swine flu strain BiondVax,s CEO Dr. ... the way towards the realization of the Company,s ... with a single vaccination." , BiondVax ...
(Date:12/7/2009)... PARIS, December 7 Merieux Alliance, ... it changes its name to take on,the ... press conference held in Paris,Alain Merieux reviewed ... in the,face of major public health challenges ... nutrition. Along with Alexandre,Merieux and the management ...
Breaking Medicine Technology:Van Andel Institute Cuts Ribbon on $178 Million Expansion 2Van Andel Institute Cuts Ribbon on $178 Million Expansion 3Van Andel Institute Cuts Ribbon on $178 Million Expansion 4Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 2Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 3Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 4Successful Phase I/II Clinical Trial for BiondVax Pharmaceuticals' Universal Flu Vaccine 5Merieux Alliance Becomes Institut Merieux 2Merieux Alliance Becomes Institut Merieux 3Merieux Alliance Becomes Institut Merieux 4Dr Julian Whitaker Pens Forward for Suzanne Somers 26apos 3B New Cancer Book 59588 1Dr Julian Whitaker Pens Forward for Suzanne Somers 26apos 3B New Cancer Book 59588 2Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 1Micro Waste Corporation Ordered to Pay Sanitecs Attorney Fees 59583 2Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 59578 1Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 59578 2Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 59578 3Mayo Clinic Clinicians Develop New Decision Aid Tool to Help Type 2 Diabetes Patients 59578 4
... Triad Skull Clamp, compatible with the full ... of clamping force on all three skull ... the possibility of adjusting the force on ... be increased or decreased by adjusting the ...
A fully automated, benchtop instrument designed for high-volume urine testing, using Siemens' proven technology in dry-pad urine chemistry analysis....
... PocketChem UA is the first ... take up valuable lab bench space. ... the variability in results between operators ... on every run, corrects for ambient ...
... sensor catheters incorporate a lumen ... wire, or high-speed injection/guide wire. ... injection has two laterally opposed ... open-end pigtail extension for use ...
Medicine Products: